Skip to main content

Table 7 Composition of HIV-1 envelope peptide pools tested

From: Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model

Peptide Pools

W61D

IIIB

SF33

V1/V2 Pool

ARP7035.6-17

ARP740.6-16

ARP7117.6-16

V3 Pool

ARP7035.22, 25-33

ARP740.21, 24-33

ARP7117.21, 24-33

V4 Pool

ARP7035.34-38, 41-48

ARP740.33-38, 41-47

ARP7117.33-38,41-46

C1 Pool

ARP7035.1-5, 20, 21

nt

nt

C2 Pool

ARP7035.18, 19, 23, 24

nt

ARP7117.17, 18, 22, 23

C3 Pool

ARP7035.39, 40

nt

nt

  1. nt = not tested.
  2. 20mer HIV-1 env gp120 peptides with 10mer overlap from CFAR, NIBSC, UK.
Back to article page

Retrovirology

ISSN: 1742-4690

Contact us